[1]
2020. Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab: A consensus statement of the Working Party on Haemostasis of the Swiss Society of Haematology and the Swiss Haemophilia Network. Swiss Medical Weekly. 150, 5153 (Dec. 2020), w20422. DOI:https://doi.org/10.4414/smw.2020.20422.